Liz Oestreich brings more than ten years of regulatory experience and diverse knowledge of legal and public policy matters to her position as Senior VP of Regulatory Compliance at ELIQUENT Life Sciences. Liz provides strategic guidance on premarket and post market issues, specifically related to regulatory compliance. She works with tobacco, pharmaceutical and medical device clients to prepare for FDA inspection and to address and remediate compliance matters. She advises clients on FDA communication, including 483 and warning letter responses, and offers guidance on agency expectations and regulatory policy. Liz also leads ELIQUENT's Advisory Services practice area, working with life science investors and industry to evaluate the potential regulatory risks during the due diligence stage of transactions.
